|
Pneumoperitoneum
|
D011027 |
[A condition with trapped gas or air in the PERITONEAL CAVITY, usually secondary to perforation of the internal organs such as the LUNG and the GASTROINTESTINAL TRACT, or to recent surgery. Pneumoperitoneum may be purposely introduced to aid radiological examination.
] |
|
Pneumoperitoneum, Artificial
|
D011028 |
[Deliberate introduction of air into the peritoneal cavity.
] |
|
Pneumoradiography
|
D011029 |
[Radiography using air, oxygen, or some other gas as a contrast medium.
] |
|
Pneumonia, Pneumocystis
|
D011020 |
[A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
] |
|
Pneumonia, Progressive Interstitial, of Sheep
|
D011021 |
[Chronic respiratory disease caused by the VISNA-MAEDI VIRUS. It was formerly believed to be identical with jaagsiekte (PULMONARY ADENOMATOSIS, OVINE) but is now recognized as a separate entity.
] |
|
Pneumonia, Rickettsial
|
D011022 |
[Pneumonia caused by infection with bacteria of the family RICKETTSIACEAE.
] |
|
ethyl m-digallate
|
C456560 |
|
|
Pneumonia, Staphylococcal
|
D011023 |
[Pneumonia caused by infections with bacteria of the genus STAPHYLOCOCCUS, usually with STAPHYLOCOCCUS AUREUS.
] |
|
adenosine 3'-ethylphosphate
|
C456561 |
|
|
Pneumonia, Viral
|
D011024 |
[Inflammation of the lung parenchyma that is caused by a viral infection.
] |
|
methoxy polyethylene glycol methacrylate
|
C456562 |
|
|
Pneumonolysis
|
D011025 |
[Division of the tissues attaching the lung to the wall of the chest cavity, to permit collapse of the lung. It was formerly used to treat tuberculosis. (Dorland, 28th ed)
] |
|
Kynurenine 3-Monooxygenase
|
D050601 |
[An NADPH-dependent flavin monooxygenase that plays a key role in the catabolism of TRYPTOPHAN by catalyzing the HYDROXYLATION of KYNURENINE to 3-hydroxykynurenine. It was formerly characterized as EC 1.14.1.2 and EC 1.99.1.5.
] |
|
4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride
|
C456520 |
|
|
Linoleoyl-CoA Desaturase
|
D050602 |
[An enzyme that catalyzes the syn-dehydrogenation of linoleol-CoA gamma-linolenoyl-CoA. It was formerly characterized as EC 1.14.99.25.
] |
|
Squalene Monooxygenase
|
D050603 |
[The second enzyme in the committed pathway for CHOLESTEROL biosynthesis, this enzyme catalyzes the first oxygenation step in the biosynthesis of STEROLS and is thought to be a rate limiting enzyme in this pathway. Specifically, this enzyme catalyzes the conversion of SQUALENE to (S)-squalene-2,3-epoxide.
] |
|
Succinate-Semialdehyde Dehydrogenase (NADP+)
|
D050604 |
[An enzyme that catalyzes the oxidation of succinate semialdehyde to SUCCINIC ACID. It plays a role in the metabolism of GLUTAMATE; TYROSINE; and butanoate.
] |
|
Malonate-Semialdehyde Dehydrogenase (Acetylating)
|
D050605 |
[An enzyme that catalyzes the oxidation of 3-oxopropanoate (malonate semialdehyde) to acetyl COENZYME A. It plays a role in the metabolism of BETA-ALANINE.
] |
|
Mannose-Binding Protein-Associated Serine Proteases
|
D050606 |
[Serum serine proteases which participate in COMPLEMENT ACTIVATION. They are activated when complexed with the MANNOSE-BINDING LECTIN, therefore also known as Mannose-binding protein-Associated Serine Proteases (MASPs). They cleave COMPLEMENT C4 and COMPLEMENT C2 to form C4b2a, the CLASSICAL PATHWAY C3 CONVERTASE.
] |
|
Organogold Compounds
|
D050607 |
[Organic compounds that contain GOLD as an integral part of the molecule. Some are used as ANTIRHEUMATIC AGENTS. The term chrysotherapy derives from an ancient Greek term for gold.
] |
